Biomedical
and Radiation-Genetic Studies Using Different Types |
Leader: |
G.V. Mitsyn |
Deputy: |
S.V. Shvidky |
Participating
countries and international organizations:
Belgium, China, Czech Republic, Moldova, Poland, Romania, Russia, South Africa, USA.
Issues
addressed and main goals of research:
Biomedical and clinical research of proton radiotherapy for cancer treatment. Formation of an experimental data base in the field of radiation mutagenesis in the animal germ cells.
Expected
results in the current year:
Evaluation of effectiveness of conducted radiation treatment of different neoplasms.
Increase of functional capability of the developed 3D treatment planning software.
Design and construction of prototype equipment for dynamic conformal irradiation of deep-seated tumours with the proton beam.
Development and improvement of detectors and tools for clinical dosimetry of medical hadron beams.
Continuation of research to determine forms of fibroblast cell death depending on the dose of ionizing radiation.
Study of mechanisms of functional and neurochemical disorders in the central nervous system during exposure to radiation with different linear energy transfer.
Mastering of new methods for evaluation of effectiveness of cytotoxic activity of nanoparticles on tumour cells.
Continuation of the molecular analysis of gamma- and neutron-induced intragenic structural changes in germline cells.
Continuation of the sequence analysis of inherited DAN changes at the genome level of the offspring.
Continuation of the work on the analysis of the transcriptome in somatic cells differing in radiosensitivity.
Assessment of radioresistance of D.melanogaster strains and the human cell line HEK293 expressing DSUP protein (gamma rays, protons, heavy ions).
Transcriptome analysis of D.melanogaster strains and the human cell line HEK293 expressing Dsup protein.
Study of distribution of GEP-Dsup fusion protein on D.melanogater polytene chromosomes.
Development of a project of a specialized isochronous cyclotron for proton therapy.
Measurements of the magnetic field of the MC1 bending magnet for the transport line of the AIC-144, Krakow, Poland.
|
|
||
|
Project |
Leader |
Priority |
1. |
Further
development of methods,
|
G.V. Mitsyn |
1 (2017-2022) |
2. |
RADIOGENE:
Molecular genetics of |
I.D. Alexandrov |
1 (2017-2022) |
3. |
Study
of the radioprotective |
E.V. Kravchenko |
1 (2021-2022) |
|
|
||||
|
Activity or Experiment |
Leaders |
Status |
||
|
Laboratory
or other |
Main researchers |
|||
1. |
Further
development of methods, |
G.V. Mitsyn |
|
||
|
DLNP |
A.V.
Agapov,
I.V.
Alexandrova,
O.V.
Belov,
K.
Belokopytova,
|
|||
2. |
RADIOGENE:
Molecular genetics |
I.D. Alexandrov |
|
||
|
DLNP |
M.V.
Alexandrova, K.P. Afanasyeva, N.E. Kharchenko, |
3. |
Study
of the radioprotective properties |
E.V. Kravchenko |
|
|
DLNP |
A.E.
Ivanova, O.A. Kuldoshina, A.V. Rzyanina, A.S. Yakunenko, M.P.
Zarubin |
4. |
Development
of methods and programs |
G.A. Karamysheva |
|
|
DLNP |
K.S.
Bunyatov, A.F. Chesnov, S.N. Dolya, S.B. Fedorenko, |
|
MLIT |
I.V. Amirhanov, T.V. Karamysheva |
Collaboration
Country or International Organization |
City |
Institute or laboratory |
Belgium |
Louvain-la-Neuve |
IBA |
China |
Hefei |
IPP CAS |
Czech Republic |
Prague |
ADVACAM |
|
|
PTC |
|
Rez |
UJV |
Moldova |
Chisinau |
MSU
|
Poland |
Krakow |
INP PAS |
|
Otwock (Swierk) |
NCBJ |
|
Poznan |
GPCC |
Romania |
Bucharest |
IFIN-HH |
Russia |
Dubna |
RDH-9 |
|
Moscow |
DMS RAS |
|
|
FMBC |
|
|
IBMP RAS |
|
|
VIGG RAS |
|
Rostov-on-Don |
SFedU |
South Africa |
Somerset West |
iThemba LABS |
USA |
Lansing, MI |
IONETIX |
▲ |